ImmuPharma plc (LON:IMM – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 8.24 and traded as low as GBX 6.50. ImmuPharma shares last traded at GBX 6.50, with a volume of 837,072 shares.
ImmuPharma Price Performance
The firm has a market cap of £32.68 million, a P/E ratio of -7.30 and a beta of 3.02. The firm’s 50-day moving average price is GBX 7.13 and its 200 day moving average price is GBX 8.24.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
Further Reading
- Five stocks we like better than ImmuPharma
- The gold chart Wall Street is terrified of…
- I tried out Elon Musk’s new AI tech — it floored me
- “I just bought 10,000 shares of a $5 stock…”
- The Next Commodity Crunch (bigger than oil?)
- Is Trump Done? Shocking leak…
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
